After more than two years of reports about early failure of hip implants, DePuy Orthopaedics issued a warning letter to doctors about the device. The warning comes months after the company, a unit of Johnson & Johnson, announced plans to phase out the product because of slowing sales, The New York Times reports. Company officials told The Times that safety issues had nothing to do with the decision to phase out the implant, called the ASR.
From The Times:
Since the beginning of 2008, the F.D.A. has received about 300 complaints on the ASR involving patients in the United States who received it. A review of those reports indicates that a vast majority of those patients underwent an operation to have the device replaced soon after getting it.
The number of such complaints typically understates a product’s problem, however, because many doctors and hospitals never bother to file reports with the F.D.A.
Last week, The Times published a story citing studies that showed metal-on-metal hip implants can cause soft-tissue and bone damage in some patients.



This a huge nationwide lawsuit against Johnson & Johnson, and a lot of people don’t know the symptoms, which vary from severe pain to implant loosening to implant dislocation. Some patients have required a second surgery to replace the defective DePuy implant.